Evidence map›Paper›PMID 41595937›Full record

ArticleBioengineering (Basel, Switzerland)2025

Explainable Computational Imaging for Precision Oncology: An Interpretable Deep Learning Framework for Bladder Cancer Histopathology Diagnosis.

Abdallah A Mohamed, Yousry AbdulAzeem, Abdullateef I Almudaifer, Hanaa ZainEldin, Hossam Magdy Balaha, Mahmoud Badawy, Mostafa A Elhosseini

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdallah A MohamedDepartment of Information Systems, College of Computer Science and Engineering, Taibah University, Yanbu 46421, Saudi Arabia.
Yousry AbdulAzeemSchool of Computational Sciences and Artificial Intelligence, Zewail City of Science, Technology and Innovation, Giza 12578, Egypt.ORCID 0000-0002-1721-481X
Abdullateef I AlmudaiferDepartment of Computer Science, College of Computer Science and Engineering, Taibah University, Yanbu 46421, Saudi Arabia.
Hanaa ZainEldinComputers and Control Systems Engineering Department, Faculty of Engineering, Mansoura University, Mansoura 35516, Egypt.
Hossam Magdy BalahaComputers and Control Systems Engineering Department, Faculty of Engineering, Mansoura University, Mansoura 35516, Egypt.ORCID 0000-0002-0686-4411
Mahmoud BadawyComputers and Control Systems Engineering Department, Faculty of Engineering, Mansoura University, Mansoura 35516, Egypt.ORCID 0000-0002-0120-3235
Mostafa A ElhosseiniDepartment of Information Systems, College of Computer Science and Engineering, Taibah University, Yanbu 46421, Saudi Arabia.ORCID 0000-0002-1259-6193

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer represents a significant health problem worldwide, with it being a major cause of death and characterized by frequent recurrences. Effective treatment hinges on early and accurate diagnosis; however, traditional methods are invasive, time-consuming, and subjective. In this research, we propose a transparent deep learning model based on the YOLOv11 structure to not only enhance lesion detection but also give the visual support of the model's predictions. Five versions of YOLOv11-nano, small, medium, large, and extra large-were trained and tested by us on a comprehensive dataset of hematoxylin and eosin-stained histopathology slides with the inflammation, urothelial cell carcinoma (UCC), and invalid tissue categories. The YOLOv11-large variant turned out to be the best-performing model at the forefront of technology, with an accuracy of 97.09%, precision and recall of 95.47% each, and balanced accuracy of 96.60%. Besides the precision-recall curves (AUPRC: inflammation = 0.935, invalid = 0.852, UCC = 0.958), ROC-AUC curves (overall AUC = 0.972) and risk-coverage analysis (AUC = 0.994) were also used for detailed assessment of the model to confirm its steadiness and trustworthiness. The confusion matrix displayed the highest true positive rates in all classes and a few misclassifications, which mainly happened between inflammation and invalid samples, indicating a possible morphological overlap. Moreover, as supported by a low Expected Calibration Error (ECE), the model was in great calibration. YOLOv11 reaches higher performance while still being computationally efficient by incorporating advanced architectural features like the C3k2 block and C2PSA spatial attention module. This is a step towards the realization of the AI-assisted bladder cancer diagnostic system that is not only reliable and transparent but also scalable, presented in this work.

Indexed as

bladder cancerdeep learninghistopathology diagnosisYou Only Look Once

Identifiers

PMID41595937
PMCPMC12837965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.